Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phenylphosphate carboxylase (EC 4.1.1.88) is a complex bacterial enzyme that facilitates the anaerobic metabolism of phenol. It catalyzes the carboxylation of phenylphosphate to 4-hydroxybenzoate using carbon dioxide as a substrate (Schühle & Fuchs, 2004). This enzyme is typically found in specialized anaerobic bacteria, such as Thauera aromatica, and is part of a larger pathway that converts toxic aromatic compounds into metabolic intermediates like benzoyl-CoA (BRENDA, EC 4.1.1.88). The protein itself is composed of four distinct subunits (alpha, beta, gamma, and delta) that operate together to ensure the regioselectivity of the carboxylation reaction (UniProt, P81478). From a clinical standpoint, phenylphosphate carboxylase is not a therapeutic target for human medicine, as it is entirely absent in humans and common pathogens. Its utility is primarily explored in environmental biotechnology for the bioremediation of phenol-contaminated anaerobic sites. Consequently, there are no approved drugs or pharmacological mechanisms associated with this enzyme in human health.
No therapeutic mechanism of action, as the enzyme is not a human drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phenylphosphate carboxylase (PPC) (PPC).